Alexion Pharmaceuticals (ALXN)
Create an Alert
91.09
-1.30 -1.41%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
Alexion Pharmaceuticals Cash from Operations Quarterly:
46.50M for March 31, 2013Alexion Pharmaceuticals Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 46.50M |
| Dec. 31, 2012 | 104.96M |
| Sept. 30, 2012 | 141.32M |
| June 30, 2012 | 101.53M |
| March 31, 2012 | 62.80M |
| Dec. 31, 2011 | 90.79M |
| Sept. 30, 2011 | 76.25M |
| June 30, 2011 | 78.68M |
| March 31, 2011 | 24.36M |
| Dec. 31, 2010 | 51.01M |
| Sept. 30, 2010 | 42.94M |
| June 30, 2010 | 45.46M |
| March 31, 2010 | 21.49M |
| Dec. 31, 2009 | 32.44M |
| Sept. 30, 2009 | 38.76M |
| June 30, 2009 | 26.71M |
| March 31, 2009 | 15.93M |
| Dec. 31, 2008 | 30.85M |
| Sept. 30, 2008 | 19.45M |
| June 30, 2008 | 14.15M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
| Oct. 31, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
ALXN Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Biogen Idec | 178.94M |
| Alkermes | 55.30M |
| Anika Therapeutics | 6.069M |
ALXN Cash from Operations Quarterly Rankings
| Overall |
90th percentile 1638 of 16782 |
| Sector |
92nd percentile 111 of 1410 in Healthcare |
| Industry |
95th percentile 19 of 454 in Biotechnology |
ALXN Cash from Operations Quarterly Range, Past 5 Years
| Minimum | 14.15M | Jun 2008 |
| Maximum | 141.32M | Sep 2012 |
| Average | 53.32M |
